These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1107 related articles for article (PubMed ID: 24125756)

  • 1. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway.
    Franklin M; Bu SY; Lerner MR; Lancaster EA; Bellmer D; Marlow D; Lightfoot SA; Arjmandi BH; Brackett DJ; Lucas EA; Smith BJ
    Bone; 2006 Dec; 39(6):1331-42. PubMed ID: 16890505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis.
    Deyhim F; Stoecker BJ; Brusewitz GH; Devareddy L; Arjmandi BH
    Menopause; 2005; 12(6):755-62. PubMed ID: 16278620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.
    Varela A; Chouinard L; Lesage E; Smith SY; Hattersley G
    J Bone Miner Res; 2017 Jan; 32(1):24-33. PubMed ID: 27748532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary supplementation with dried plum prevents ovariectomy-induced bone loss while modulating the immune response in C57BL/6J mice.
    Rendina E; Lim YF; Marlow D; Wang Y; Clarke SL; Kuvibidila S; Lucas EA; Smith BJ
    J Nutr Biochem; 2012 Jan; 23(1):60-8. PubMed ID: 21414765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
    McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
    Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
    Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
    Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
    Wang L; Orhii PB; Banu J; Kalu DN
    Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats.
    Wang L; Orhii PB; Banu J; Kalu DN
    Bone; 2001 Feb; 28(2):202-7. PubMed ID: 11182379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats.
    Bu SY; Lucas EA; Franklin M; Marlow D; Brackett DJ; Boldrin EA; Devareddy L; Arjmandi BH; Smith BJ
    Osteoporos Int; 2007 Jul; 18(7):931-42. PubMed ID: 17554580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model.
    Ardawi MM; Badawoud MH; Hassan SM; Rouzi AA; Ardawi JMS; AlNosani NM; Qari MH; Mousa SA
    Bone; 2016 Feb; 83():127-140. PubMed ID: 26549245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
    Iwaniec UT; Moore K; Rivera MF; Myers SE; Vanegas SM; Wronski TJ
    Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.